1Department of Pharmacology, Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia
2Department of Internal Medicine, Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia
3Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia
SLE is an autoimmune disease that has very complex pathogenesis. SLE patients have more sensitive B cells and reduced regulator T cell activity. The increase in activityof B which has play a role in the absorption and presentation of autoantigens to T cells. B cells and T cells will also affect the production of cytokines such as TNF α and TGF-β. We used forty female BALB/c mice, aged 6 until 8 weeks old received a single intraperitoneal injection of 0.5 cc pristane for lupus induction. At 16 weeks after injection, pristane-induced lupus mice were divided into four groups based on the doses received by intragastrically: 10.5mg/kg/day, 21 mg/kg/day, and 42mg/kg/day for 12 weeks. At 38 weeks after injection, all of mice were assessed for inflammation marker. Study results showed that percentages of maturation of B cells, TNF-α, were decreased (p<0.05) and percentages of TGF-β were increased (p>0.05) in
Systemic Lupus Erythematosus, Bryophyllum pinnatum, Tumor Necrosis Factor α, Tumor Necrosis Factor β